All patients underwent MRI on a 3 T MRI system (Ingenia; Philips Medical Systems, Best, the Netherlands) with a Head/Neck coil. The pulse sequence parameters were as follows. T2-weighted imaging with a TSE sequence: repetition time (TR)/echo time (TE), 6528/90 ms; number of signals averaged (NSA), 1; field of view (FOV), 240 × 240 mm; matrix, 384 × 271; slice thickness, 4 mm; number of slices, 22; acceleration factor, 1.5; and scanning time, 1 min 57 s. T1-weighted imaging with a TSE sequence: TR/TE, 614/14 ms; NSA, 1; FOV, 240 × 240 mm; matrix, 352 × 246; slice thickness, 4 mm; number of slices, 22; acceleration factor, 2; and acquisition time, 2 min 34 s. DWI with a spin-echo, echo-planar sequence: TR/TE, 5000/88 ms; fat suppression, short-tau inversion recovery; inversion time, 250 ms; NSA, 2; b value, 0 and 1000 s/mm2; FOV, 240 × 240 mm; matrix, 96 × 125; slice thickness, 4 mm; number of slices, 22; acceleration factor, 2; and acquisition time, 3 min 30 s. Contrast-enhanced 3D-T1-weighted imaging with a gradient-echo sequence: slice orientation, sagittal; TR/TE, 5.3/2.4 ms; flip angle (FA), 10; fat suppression, spectral-attenuated inversion recovery; FOV, 250 × 225 mm; matrix, 256 × 256; slice thickness, 1 mm; number of slices, 180; acceleration factor, 1.8; and acquisition time, 3 min 24 s. The contrast-enhanced 2D-T1-weighted imaging parameters were the same as the non-contrast parameters.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.